Drug Profile
Research programme: chronic pain therapies - Seelos Therapeutics
Alternative Names: Lidocaine - Seelos Therapeutics; Lidocaine/prilocaine - Seelos Therapeutics; NM 30088Latest Information Update: 29 Jan 2019
Price :
$50
*
At a glance
- Originator NexMed
- Developer Apricus Biosciences
- Class
- Mechanism of Action Sodium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Pain